Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae among clinical isolates in Turaif general hospital, northern borders- Saudi Arabia
The Journal of Infection in Developing Countries · 30.04.2023 · 17 (04) · 477-484
DOI: 10.3855/jidc.17212 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 30.04.2023. Verfasst von Eman A El-Masry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and immunology unit, Department of Pathology, College of Medicine, Jouf University, Al-Jouf, Saudi Arabia. Hauptthemen laut MEDLINE: Hospitals, General, Escherichia coli. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Al Jouf University.
Abstract (Originalsprache)
Introduction
Enterobacteriaceae that produce extended-spectrum beta-lactamase (ESBL) are quickly spreading, posing a threat to world healthcare. Methodology: 138 gram-negative bacteria were collected from different samples (stool, urine, wound, blood, tracheal aspirate, catheter tip, vaginal swab, sputum, and tracheal aspirate) from hospitalized patients. Samples were subcultured and identified in accordance with their biochemical reactions and culture characteristics. Against all the isolated Enterobacteriaceae, an antimicrobial susceptibility test was performed. VITEK®2 system, phenotypic confirmation, and Double-Disk Synergy Test (DDST) had been utilized to identify the ESBLs.
Results
Of the 138 samples studied, the prevalence of ESBL-producing infections among the clinical samples of the present study was 26.8 % (n = 37). E. coli was the commonest ESΒL producer at 51.4% (n = 19) followed by K. pneumoniae at 27% (n = 10). The potential risk factors for the ESBL development that produces bacteria were as follows, patients with the presence of indwelling devices, previous history of hospital admission, and usage of antibiotics. ESBL is statistically (p ≤ 0.05) higher among the patients with indwelling devices, ICU admission, who had a previous hospital admission in the last 6 months as well as who was given antibiotics (quinolones and/or cephalosporins) in the last 6 months. One hundred thirty-two (95.7%) of ESBL isolates were resistant to amoxicillin, while the lowest resistance was for fosfomycin (15.2%).
Conclusions
ESBL-producing Enterobacteriaceae are highly prevalent in Turaif General Hospital setting with some potential risk factors. A strict policy to be made available on the usage of antimicrobials in hospitals and clinics should be established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology and immunology unit, Department of Pathology, College of Medicine, Jouf University, Al-Jouf, Saudi Arabia.
- Master's Degree in infection prevention and control, Primary health care center, Suwayr, Al-Jouf, Saudi Arabia.
Förderung
- Al Jouf University
Zitieren
APA
El-Masry, E. A., Alruwaili, F. M., Taha, A. E., Saad, A. E., & Taher, I. A. (2023). Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae among clinical isolates in Turaif general hospital, northern borders- Saudi Arabia. The Journal of Infection in Developing Countries, 17(04), 477-484. https://doi.org/10.3855/jidc.17212
Vancouver
El-Masry EA, Alruwaili FM, Taha AE, Saad AE, Taher IA. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae among clinical isolates in Turaif general hospital, northern borders- Saudi Arabia. The Journal of Infection in Developing Countries. 2023;17(04):477-484. doi:10.3855/jidc.17212
BibTeX
@article{ElMasry2023,
author = {El-Masry, Eman A and Alruwaili, Faisal Mansour and Taha, Ahmed E and Saad, Abeer E and Taher, Ibrahim A},
title = {Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae among clinical isolates in Turaif general hospital, northern borders- Saudi Arabia},
journal = {The Journal of Infection in Developing Countries},
year = {2023},
volume = {17},
number = {04},
pages = {477--484},
doi = {10.3855/jidc.17212}
}
EUVIMED